Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Statins, PPIs Lead Chronic Drug Classes In Part D “Induced Demand”

Executive Summary

Demand for statins and proton pump inhibitors showed solid gains among Medicare Part D enrollees in 2006, according to a recently released 1report from IMS Health

You may also be interested in...



Pharma Sales Growth: 2007 Starts High, But Expected To Taper By Year-End

BOSTON - Despite a strong start to 2007, growth in the pharmaceutical sector is expected to slow for the remainder of the year. According to IMS Health VP-Industry Relations Doug Long, "2007 has been a year that you could characterize as a fast start, slow finish.

Insurer Seeks To Recover ‘Illegal’ Daraprim Overcharges Due To Obstruction Of Generics

Proposed class action lawsuit by Blue Cross Blue Shield of Minnesota against Vyera Pharmaceuticals could set a precedent for other health insurer actions against manufacturers.

UsernamePublicRestriction

Register

ID1132956

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel